160 related articles for article (PubMed ID: 36373433)
1. Anti-Valosin-Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies.
Amlani A; Choi MY; Buhler KA; Hudson M; Tarnopolsky M; Brady L; Schmeling H; Swain MG; Stingl C; Reed A; Fritzler MJ
ACR Open Rheumatol; 2023 Jan; 5(1):10-14. PubMed ID: 36373433
[TBL] [Abstract][Full Text] [Related]
2. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
Front Immunol; 2019; 10():745. PubMed ID: 31024569
[No Abstract] [Full Text] [Related]
3. Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.
Kramp SL; Karayev D; Shen G; Metzger AL; Morris RI; Karayev E; Lam Y; Kazdan RM; Pruijn GJ; Saschenbrecker S; Dähnrich C; Schlumberger W
Auto Immun Highlights; 2016 Dec; 7(1):16. PubMed ID: 27858337
[TBL] [Abstract][Full Text] [Related]
4. Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases.
Diederichsen LP; Iversen LV; Nielsen CT; Jacobsen S; Hermansen ML; Witting N; Cortes R; Korsholm SS; Krogager ME; Friis T
Muscle Nerve; 2023 Jul; 68(1):73-80. PubMed ID: 37177880
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M
Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351
[TBL] [Abstract][Full Text] [Related]
6. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ
Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies.
Ikenaga C; Findlay AR; Goyal NA; Robinson S; Cauchi J; Hussain Y; Wang LH; Kershen JC; Beson BA; Wallendorf M; Bucelli RC; Mozaffar T; Pestronk A; Weihl CC
Ann Clin Transl Neurol; 2021 Mar; 8(3):571-578. PubMed ID: 33556224
[TBL] [Abstract][Full Text] [Related]
9. Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?
Miyachi K; Hosaka H; Nakamura N; Miyakawa H; Mimori T; Shibata M; Matsushima S; Chinoh H; Horigome T; Hankins RW; Zhang M; Fritzler MJ
Scand J Immunol; 2006 May; 63(5):376-82. PubMed ID: 16640662
[TBL] [Abstract][Full Text] [Related]
10. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.
Gang Q; Bettencourt C; Machado PM; Brady S; Holton JL; Pittman AM; Hughes D; Healy E; Parton M; Hilton-Jones D; Shieh PB; Needham M; Liang C; Zanoteli E; de Camargo LV; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Singleton AB; Hanna MG; Houlden H;
Neurobiol Aging; 2016 Nov; 47():218.e1-218.e9. PubMed ID: 27594680
[TBL] [Abstract][Full Text] [Related]
11. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.
Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y
Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044
[TBL] [Abstract][Full Text] [Related]
12. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.
Lloyd TE; Christopher-Stine L; Pinal-Fernandez I; Tiniakou E; Petri M; Baer A; Danoff SK; Pak K; Casciola-Rosen LA; Mammen AL
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):66-71. PubMed ID: 25892010
[TBL] [Abstract][Full Text] [Related]
14. Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis.
Paul P; Liewluck T; Ernste FC; Mandrekar J; Milone M
Muscle Nerve; 2021 Apr; 63(4):490-496. PubMed ID: 33373040
[TBL] [Abstract][Full Text] [Related]
15. [Sporadic Inclusion Body Myositis and Autoantibodies].
Yamashita S; Ando Y
Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292
[TBL] [Abstract][Full Text] [Related]
16. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.
Weihl CC; Baloh RH; Lee Y; Chou TF; Pittman SK; Lopate G; Allred P; Jockel-Balsarotti J; Pestronk A; Harms MB
Neuromuscul Disord; 2015 Apr; 25(4):289-96. PubMed ID: 25617006
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies.
Lee SA; Lee HJ; Suh BC; Shin HY; Kim SW; Yoon BA; Choi YC; Park HJ
PLoS One; 2023; 18(4):e0284409. PubMed ID: 37058449
[TBL] [Abstract][Full Text] [Related]
18. Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility.
Herbert MK; Pruijn GJ
Curr Opin Rheumatol; 2015 Nov; 27(6):595-600. PubMed ID: 26285103
[TBL] [Abstract][Full Text] [Related]
19. Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.
Goyal NA; Cash TM; Alam U; Enam S; Tierney P; Araujo N; Mozaffar FH; Pestronk A; Mozaffar T
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):373-8. PubMed ID: 25857661
[TBL] [Abstract][Full Text] [Related]
20. Autophagy, inflammation and innate immunity in inflammatory myopathies.
Cappelletti C; Galbardi B; Kapetis D; Vattemi G; Guglielmi V; Tonin P; Salerno F; Morandi L; Tomelleri G; Mantegazza R; Bernasconi P
PLoS One; 2014; 9(11):e111490. PubMed ID: 25365350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
